…ndividuals to make a plan selection 60 days before and after certain triggering events when enrolling inside or outside the individual market Exchanges. Finally, we proposed amending § 147.104(b)(1)(i)(C) to update the citation to the SHOP regulations to conform with changes made…
… regional plan program. The definition of “essential hospital” in the statute prevents such an outcome. Section 1858(h)(4) of the Act is clear in defining an “essential hospital” as a “subsection (d) hospital,” as that term is defined at section 1886(d)(1)(B) of the Act. CAHs are…
…e to cover a majority of the same counties in its service area. This standard prevents significant reductions in a product's service area; however, service area expansions of any degree would satisfy this standard, provided that a majority of the original product service area rem…
…e to cover a majority of the same counties in its service area. This standard prevents significant reductions in a product's service area; however, service area expansions of any degree would satisfy this standard, provided that a majority of the original product service area rem…
…e to cover a majority of the same counties in its service area. This standard prevents significant reductions in a product's service area; however, service area expansions of any degree would satisfy this standard, provided that a majority of the original product service area rem…
…e to cover a majority of the same counties in its service area. This standard prevents significant reductions in a product's service area; however, service area expansions of any degree would satisfy this standard, provided that a majority of the original product service area rem…
…e to cover a majority of the same counties in its service area. This standard prevents significant reductions in a product's service area; however, service area expansions of any degree would satisfy this standard, provided that a majority of the original product service area rem…
…'s AI Showcase, held in late 2022, available at https://www.healthit.gov/news/events/onc-artificial-intelligence-showcase-seizing-opportunities-and-managing-risks-use-ai and this year's issuance of a notice of proposed rulemaking for Health Data, Technology, and Interoperabili…
…nition C. Exceptions 1. Infeasibility a. Infeasibility Exception—Uncontrollable Events Condition b. Infeasibility Exception—Third Party Seeking Modification Use Summary of Finalized Policy: Third Party Seeking Modification Use Condition c. Infeasibility Exception—Manner Exception…
…nsists of six weeks or more of intravenous antibiotics that can lead to adverse events such as acute kidney injury and the development of multidrug resistant bacteria. The applicant reiterated that CERAMENT® G's unique mechanism of action is that it elutes gentamicin (the antimic…
…nition C. Exceptions 1. Infeasibility a. Infeasibility Exception—Uncontrollable Events Condition b. Infeasibility Exception—Third Party Seeking Modification Use Summary of Finalized Policy: Third Party Seeking Modification Use Condition c. Infeasibility Exception—Manner Exception…
…ct the availability, integrity, and security of data during unexpected negative events. Data are often most exposed in these events, since the usual security measures may be disabled, ignored, or not observed. Each entity needs to determine its own risk in the event of an emergen…
… highly skilled in evaluating patients and managing clinical issues and adverse events that commonly arise during the procedure, particularly in patients with comorbid anemia, renal failure, cardiovascular disease, serum protein abnormalities or other risk factors. [ 25 ] Their k…
…products. Also, claim lines billed with P9099 are rejected by Medicare, which prevents providers from tracking the utilization of unclassified blood products. Because of the challenges of determining an appropriate payment rate for unclassified blood products, we stated in the CY…
…products. Also, claim lines billed with P9099 are rejected by Medicare, which prevents providers from tracking the utilization of unclassified blood products. Because of the challenges of determining an appropriate payment rate for unclassified blood products, we stated in the CY…